Evaluating screening practices for neurocysticercosis.
Official title: EVALUATING NEUROCYSTICERCOSIS SCREENING PRACTICES AND EPIDEMIOLOGY.
Funded at Baylor College of Medicine · NIH-11030244 · Data updated 2026-11-12
This study is looking into how common neurocysticercosis is and how we can find it early in people who might be at risk, so we can help prevent serious symptoms like headaches and seizures before they start.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | February 7, 2024 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $77,843 |
| NIH project number | 5U3RAI176054-02 |
| Project ID | NIH-11030244 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals from endemic regions who may have been exposed to the pork tapeworm.
✕Less likely to help
Patients who have no history of exposure to Taenia solium or who do not exhibit any symptoms related to neurocysticercosis may not benefit from this research.
What this research studies
This research investigates the prevalence and screening methods for neurocysticercosis, a serious condition caused by the pork tapeworm. It aims to develop an inexpensive screening protocol to identify individuals at risk before they show symptoms, which can include headaches and seizures. By analyzing the epidemiology of the disease, the study seeks to establish guidelines for early detection and intervention. This could significantly reduce the long-term health impacts associated with neurocysticercosis.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and treatment of neurocysticercosis, reducing morbidity and improving patient outcomes.
How similar studies have gone: Previous research has shown success in developing screening protocols for similar infectious diseases, indicating potential for this approach.
Where this research is happening
-
Baylor College of Medicine
Houston, United States Active
Researchers
- Principal investigator: Clark, Eva H — Baylor College of Medicine
- Study coordinator: Clark, Eva H
Related research
Other NIH-funded projects on the same topics.
-
Multimodal AI to improve genetic diagnosis of congenital heart disease
A new AI tool uses multiple types of patient data to help doctors find genetic causes of congenital heart disease more accurately.
-
Surveillance of Vaccine-Preventable Diseases in Children
This project watches how often common vaccines prevent illnesses in kids who are in the hospital or at the emergency department, and compares them with healthy children getting well-child care.
-
Triple gene therapy approach to heal the heart after a heart attack
A new therapy combines three genetic approaches delivered by a virus to help the heart heal after a heart attack.
-
Thalamic sleep circuit changes in Alzheimer's disease
Aims to understand how sleep-related brain activity in a key sleep regulator called the TRN affects Alzheimer’s progression and whether boosting TRN function could slow symptoms.
-
Cardiomyocyte-fibroblast signaling in atrial fibrillation
A researcher at Baylor College of Medicine is studying how signals between heart muscle cells and supportive heart cells influence atrial fibrillation, with the goal of finding new ways to prevent or treat this common heart rhythm problem.
-
UMPIRE: Keeping Kidneys Healthy for Babies with Spina Bifida
A care protocol for newborns with spina bifida aims to protect kidney function by thoughtful bladder management and monitoring from birth.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.